HBI Deals+Insights / News

UK launches £400 million public-private partnership to address critical need in pharmaceutical testing

The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities. Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.